Prevalence of psychiatric distress and substance abuse disorders in a high risk obstetric population.

被引:0
|
作者
Sheikh, AU
Johnson, R
Logan, S
机构
[1] Univ S Alabama, Mobile, AL 36688 USA
[2] Univ Oklahoma, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
723
引用
收藏
页码:315A / 315A
页数:1
相关论文
共 50 条
  • [1] The prevalence of chemical substance and alcohol abuse in an obstetric population in Dublin
    Bosio, P
    Keenan, E
    Gleeson, R
    Dorman, A
    Clarke, T
    Darling, M
    OConnor, J
    IRISH MEDICAL JOURNAL, 1997, 90 (04) : 149 - 150
  • [2] The Prevalence of Personality Disorder in a Psychiatric and Substance Abuse Population in Jamaica
    Walcott, G.
    Martin, J.
    Hickling, F. W.
    WEST INDIAN MEDICAL JOURNAL, 2013, 62 (05): : 458 - 462
  • [3] Comorbidity of psychiatric and substance abuse disorders
    George, TP
    Krystal, JH
    CURRENT OPINION IN PSYCHIATRY, 2000, 13 (03) : 327 - 331
  • [4] Distress prevalence and associated risk factors within the urothelial cancer population.
    Ralston, Laurel
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [5] Adolescent Substance Abuse: Psychiatric Comorbidity and High Risk Behaviors
    Fortuna, Lisa R.
    PSYCHIATRIC SERVICES, 2009, 60 (01) : 128 - 128
  • [6] Comorbidity of substance abuse and other psychiatric disorders
    Hafeiz, HB
    ANNALS OF SAUDI MEDICINE, 1996, 16 (04) : 464 - 467
  • [7] SUBSTANCE-ABUSE DISORDERS - A PSYCHIATRIC PRIORITY
    KHANTZIAN, EJ
    AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (10): : 1291 - 1300
  • [8] Comorbidity of substance abuse with other psychiatric disorders
    Palomo, Tomas
    Archer, Trevor
    Kostrzewa, Richard M.
    Beninger, Richard J.
    NEUROTOXICITY RESEARCH, 2007, 12 (01) : 17 - 27
  • [10] Psychiatric disorders, violence and their relationship with substance abuse
    Leon Caballero, J.
    Llobet Farre, M.
    Corcoles Martinez, D.
    Bellsola Gonzalez, M.
    Gonzalez Fresnero, A.
    Nascimento Osorio, M. T.
    Malagon Amor, M. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S299 - S299